ERYTECH provides business update and financial results for the first half of 2015 Post author:admERY Post published:September 28, 2015 Post category:Newsroom ERYTECH provides a business update and reports its financial results for the six-month period ending June 30, 2015. You Might Also Like ERYTECH Achieves Milestones in TRYbeCA1 Phase 3 Trial of Eryaspase in Second-line Pancreatic Cancer November 4, 2019 ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer December 14, 2020 ERYTECH completes enrollment in its Phase III study in Acute Lymphoblastic Leukemia September 10, 2013
ERYTECH Achieves Milestones in TRYbeCA1 Phase 3 Trial of Eryaspase in Second-line Pancreatic Cancer November 4, 2019
ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer December 14, 2020
ERYTECH completes enrollment in its Phase III study in Acute Lymphoblastic Leukemia September 10, 2013
